News

Categories
Sign up
Featured Posts
Archive
Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

The Introduction of Alpha DaRT in Russia for Treatment of Metastatic Breast Cancer

On November 28, 2019, the first Alpha DaRT procedure was performed in Russia, at the A. Tsyb Medical Radiological Research Center in Obninsk, in a patient diagnosed with metastatic breast cancer. Radiation Oncologist Dr. Razvan Galalae from Essen, Germany, performed the treatment with the support of Prof. Yona Keisari, Chief Scientific Officer of Alpha Tau and a co-inventor of Alpha DaRT. This patient is the first in a clinical trial of Alpha DaRT just initiated in Obninsk. Breast cancer is the most common cancer among women in Russia, and is usually treated with beta or gamma radiation. Nonetheless, metastatic breast cancer is almost always fatal. Russian oncology team members who participa

How Israeli technology saved 78-year-old Leah from skin cancer

In August 2018, Jonathan and Na’ama Ellman, an Israeli couple living in the United States, brought their two-year-old son Ari to the emergency room for uncontrolled vomiting. Their whole world seemed to shatter when the doctors realized that the problem was caused by a large tumor in the lower part of his brain. A complex procedure known as transnasal endoscopic skull base surgery, essentially aiming to remove the tumor through the nose, had successfully treated similar cases in the past, but had never been performed on such a young child, which presented a whole set of additional challenges. A team at the Lucile Packard Children’s Hospital in Stanford, California, agreed to perform the oper

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

As the new Chief Medical Officer of Alpha Tau Medical, I passionately believe that the success of our new alpha-emitting radiation therapy, Alpha DaRT, has the potential to create a paradigm shift in cancer care. Despite advances in conventional therapies, there are still many patients who succumb to their disease or who are unable to tolerate existing treatments. I am proud to be part of an Israeli startup company that is working to expand cancer care for millions of patients worldwide. Looking to make a global impact in improved patient care As I began my medical career, I chose to specialize in radiation oncology. This field specifically attracted me because it blends together three impor

Alpha Tau

Looking for clinical trials?

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon